Comparative treatment trial of Augmentin versus cefaclor for acute otitis media with effusion

C. M. Odio, H. Kusmiesz, S. Shelton, J. D. Nelson

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

A total of 150 children with acute otitis media were randomly allocated to treatment with amoxicillin-potassium clavulanate (Augmentin) or with cefaclor. Each drug was given in a daily dosage of approximately 40 mg/kg in 3 divided doses for 10 days. Tympanocentesis done before treatment yielded specimens that contained pneumococcus or Haemophilus sp or both in 67% of specimens. Viridans group streptococci were isolated from 10% of specimens and Branhamella catarrhalis from 6%. Patients were scheduled for follow-up examinations at midtreatment, end of therapy, and at 30, 60, and 90 days. Of the 150 children, 130 were evaluable. Five of 60 patients (8%) treated with acute cefaclor were considered therapeutic failures because of persistent purulent drainage and isolation of the original pathogen or suprainfection. There were no failures among patients treated with Augmentin (P = .019). Rates of relapse, recurrent acute otitis media with effusion, and persistent middle ear effusion were comparable in the 2 groups of patients. Diaper rash, or loose stools, or both were significantly more common in children treated with Augmentin (34%) than in those taking cefaclor (12%), but in no case was it necessary to discontinue medication because of these mild side effects (P = .002). Cefaclor therapy was discontinued in 1 patient because of severe abdominal pain and vomiting. In this study, treatment with Augmentin was superior to treatment with cefaclor in the acute phase of acute otitis media with effusion, but Augmentin produced more adverse effects. The rates of persistent middle ear effusion and recurrent acute otitis media with effusion were comparable with the 2 regimens.

Original languageEnglish (US)
Pages (from-to)819-826
Number of pages8
JournalPediatrics
Volume75
Issue number5
StatePublished - 1985

Fingerprint

Cefaclor
Amoxicillin-Potassium Clavulanate Combination
Otitis Media with Effusion
Therapeutics
Diaper Rash
Viridans Streptococci
Haemophilus
Moraxella (Branhamella) catarrhalis
Clavulanic Acid
Amoxicillin
Otitis Media
Streptococcus pneumoniae
Abdominal Pain
Vomiting
Drainage
Recurrence

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Comparative treatment trial of Augmentin versus cefaclor for acute otitis media with effusion. / Odio, C. M.; Kusmiesz, H.; Shelton, S.; Nelson, J. D.

In: Pediatrics, Vol. 75, No. 5, 1985, p. 819-826.

Research output: Contribution to journalArticle

Odio, C. M. ; Kusmiesz, H. ; Shelton, S. ; Nelson, J. D. / Comparative treatment trial of Augmentin versus cefaclor for acute otitis media with effusion. In: Pediatrics. 1985 ; Vol. 75, No. 5. pp. 819-826.
@article{730da9c2b5104d07b1acbff8da6d7134,
title = "Comparative treatment trial of Augmentin versus cefaclor for acute otitis media with effusion",
abstract = "A total of 150 children with acute otitis media were randomly allocated to treatment with amoxicillin-potassium clavulanate (Augmentin) or with cefaclor. Each drug was given in a daily dosage of approximately 40 mg/kg in 3 divided doses for 10 days. Tympanocentesis done before treatment yielded specimens that contained pneumococcus or Haemophilus sp or both in 67{\%} of specimens. Viridans group streptococci were isolated from 10{\%} of specimens and Branhamella catarrhalis from 6{\%}. Patients were scheduled for follow-up examinations at midtreatment, end of therapy, and at 30, 60, and 90 days. Of the 150 children, 130 were evaluable. Five of 60 patients (8{\%}) treated with acute cefaclor were considered therapeutic failures because of persistent purulent drainage and isolation of the original pathogen or suprainfection. There were no failures among patients treated with Augmentin (P = .019). Rates of relapse, recurrent acute otitis media with effusion, and persistent middle ear effusion were comparable in the 2 groups of patients. Diaper rash, or loose stools, or both were significantly more common in children treated with Augmentin (34{\%}) than in those taking cefaclor (12{\%}), but in no case was it necessary to discontinue medication because of these mild side effects (P = .002). Cefaclor therapy was discontinued in 1 patient because of severe abdominal pain and vomiting. In this study, treatment with Augmentin was superior to treatment with cefaclor in the acute phase of acute otitis media with effusion, but Augmentin produced more adverse effects. The rates of persistent middle ear effusion and recurrent acute otitis media with effusion were comparable with the 2 regimens.",
author = "Odio, {C. M.} and H. Kusmiesz and S. Shelton and Nelson, {J. D.}",
year = "1985",
language = "English (US)",
volume = "75",
pages = "819--826",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "5",

}

TY - JOUR

T1 - Comparative treatment trial of Augmentin versus cefaclor for acute otitis media with effusion

AU - Odio, C. M.

AU - Kusmiesz, H.

AU - Shelton, S.

AU - Nelson, J. D.

PY - 1985

Y1 - 1985

N2 - A total of 150 children with acute otitis media were randomly allocated to treatment with amoxicillin-potassium clavulanate (Augmentin) or with cefaclor. Each drug was given in a daily dosage of approximately 40 mg/kg in 3 divided doses for 10 days. Tympanocentesis done before treatment yielded specimens that contained pneumococcus or Haemophilus sp or both in 67% of specimens. Viridans group streptococci were isolated from 10% of specimens and Branhamella catarrhalis from 6%. Patients were scheduled for follow-up examinations at midtreatment, end of therapy, and at 30, 60, and 90 days. Of the 150 children, 130 were evaluable. Five of 60 patients (8%) treated with acute cefaclor were considered therapeutic failures because of persistent purulent drainage and isolation of the original pathogen or suprainfection. There were no failures among patients treated with Augmentin (P = .019). Rates of relapse, recurrent acute otitis media with effusion, and persistent middle ear effusion were comparable in the 2 groups of patients. Diaper rash, or loose stools, or both were significantly more common in children treated with Augmentin (34%) than in those taking cefaclor (12%), but in no case was it necessary to discontinue medication because of these mild side effects (P = .002). Cefaclor therapy was discontinued in 1 patient because of severe abdominal pain and vomiting. In this study, treatment with Augmentin was superior to treatment with cefaclor in the acute phase of acute otitis media with effusion, but Augmentin produced more adverse effects. The rates of persistent middle ear effusion and recurrent acute otitis media with effusion were comparable with the 2 regimens.

AB - A total of 150 children with acute otitis media were randomly allocated to treatment with amoxicillin-potassium clavulanate (Augmentin) or with cefaclor. Each drug was given in a daily dosage of approximately 40 mg/kg in 3 divided doses for 10 days. Tympanocentesis done before treatment yielded specimens that contained pneumococcus or Haemophilus sp or both in 67% of specimens. Viridans group streptococci were isolated from 10% of specimens and Branhamella catarrhalis from 6%. Patients were scheduled for follow-up examinations at midtreatment, end of therapy, and at 30, 60, and 90 days. Of the 150 children, 130 were evaluable. Five of 60 patients (8%) treated with acute cefaclor were considered therapeutic failures because of persistent purulent drainage and isolation of the original pathogen or suprainfection. There were no failures among patients treated with Augmentin (P = .019). Rates of relapse, recurrent acute otitis media with effusion, and persistent middle ear effusion were comparable in the 2 groups of patients. Diaper rash, or loose stools, or both were significantly more common in children treated with Augmentin (34%) than in those taking cefaclor (12%), but in no case was it necessary to discontinue medication because of these mild side effects (P = .002). Cefaclor therapy was discontinued in 1 patient because of severe abdominal pain and vomiting. In this study, treatment with Augmentin was superior to treatment with cefaclor in the acute phase of acute otitis media with effusion, but Augmentin produced more adverse effects. The rates of persistent middle ear effusion and recurrent acute otitis media with effusion were comparable with the 2 regimens.

UR - http://www.scopus.com/inward/record.url?scp=0021881182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021881182&partnerID=8YFLogxK

M3 - Article

C2 - 4039433

AN - SCOPUS:0021881182

VL - 75

SP - 819

EP - 826

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 5

ER -